CN108402472B - 一种女用蚕蛹提取生物蛋白 - Google Patents
一种女用蚕蛹提取生物蛋白 Download PDFInfo
- Publication number
- CN108402472B CN108402472B CN201810495583.8A CN201810495583A CN108402472B CN 108402472 B CN108402472 B CN 108402472B CN 201810495583 A CN201810495583 A CN 201810495583A CN 108402472 B CN108402472 B CN 108402472B
- Authority
- CN
- China
- Prior art keywords
- female
- powder
- female silkworm
- silkworm
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000255789 Bombyx mori Species 0.000 title claims abstract description 113
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 75
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 75
- 238000000034 method Methods 0.000 title abstract description 10
- 239000000843 powder Substances 0.000 claims abstract description 70
- 102000008186 Collagen Human genes 0.000 claims abstract description 59
- 108010035532 Collagen Proteins 0.000 claims abstract description 59
- 229920001436 collagen Polymers 0.000 claims abstract description 59
- 241000382353 Pupa Species 0.000 claims abstract description 43
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 36
- 230000000694 effects Effects 0.000 claims abstract description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 27
- 239000002994 raw material Substances 0.000 claims abstract description 24
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims abstract description 20
- 210000004369 blood Anatomy 0.000 claims abstract description 20
- 229960001031 glucose Drugs 0.000 claims abstract description 20
- 229940109850 royal jelly Drugs 0.000 claims abstract description 20
- 239000008280 blood Substances 0.000 claims abstract description 19
- 230000036039 immunity Effects 0.000 claims abstract description 19
- 229940088597 hormone Drugs 0.000 claims abstract description 13
- 239000005556 hormone Substances 0.000 claims abstract description 13
- 230000001105 regulatory effect Effects 0.000 claims abstract description 6
- 239000000243 solution Substances 0.000 claims description 40
- 239000000047 product Substances 0.000 claims description 39
- 239000000706 filtrate Substances 0.000 claims description 18
- 238000002360 preparation method Methods 0.000 claims description 17
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 15
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 12
- 238000001914 filtration Methods 0.000 claims description 12
- 241000251468 Actinopterygii Species 0.000 claims description 10
- 238000000227 grinding Methods 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 10
- 108090000790 Enzymes Proteins 0.000 claims description 9
- 102000004190 Enzymes Human genes 0.000 claims description 9
- 239000004365 Protease Substances 0.000 claims description 9
- 238000001035 drying Methods 0.000 claims description 9
- 229940088598 enzyme Drugs 0.000 claims description 9
- 238000007873 sieving Methods 0.000 claims description 9
- 238000002791 soaking Methods 0.000 claims description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 8
- 230000001877 deodorizing effect Effects 0.000 claims description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 6
- 238000005238 degreasing Methods 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- 239000002244 precipitate Substances 0.000 claims description 6
- 238000004332 deodorization Methods 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 4
- 108010004032 Bromelains Proteins 0.000 claims description 3
- 102000029816 Collagenase Human genes 0.000 claims description 3
- 108060005980 Collagenase Proteins 0.000 claims description 3
- 229920002261 Corn starch Polymers 0.000 claims description 3
- 108090000526 Papain Proteins 0.000 claims description 3
- 108091005804 Peptidases Proteins 0.000 claims description 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 3
- 235000019835 bromelain Nutrition 0.000 claims description 3
- 238000004140 cleaning Methods 0.000 claims description 3
- 229960002424 collagenase Drugs 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 239000008120 corn starch Substances 0.000 claims description 3
- 230000009849 deactivation Effects 0.000 claims description 3
- 238000011033 desalting Methods 0.000 claims description 3
- 230000001804 emulsifying effect Effects 0.000 claims description 3
- 238000004108 freeze drying Methods 0.000 claims description 3
- 230000007062 hydrolysis Effects 0.000 claims description 3
- 238000006460 hydrolysis reaction Methods 0.000 claims description 3
- 239000005457 ice water Substances 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 3
- 238000002386 leaching Methods 0.000 claims description 3
- 239000012528 membrane Substances 0.000 claims description 3
- 238000001728 nano-filtration Methods 0.000 claims description 3
- 230000007935 neutral effect Effects 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- 235000019834 papain Nutrition 0.000 claims description 3
- 229940055729 papain Drugs 0.000 claims description 3
- 239000003208 petroleum Substances 0.000 claims description 3
- 238000001556 precipitation Methods 0.000 claims description 3
- 235000019419 proteases Nutrition 0.000 claims description 3
- 239000011347 resin Substances 0.000 claims description 3
- 229920005989 resin Polymers 0.000 claims description 3
- 235000019991 rice wine Nutrition 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 238000001694 spray drying Methods 0.000 claims description 3
- 238000000108 ultra-filtration Methods 0.000 claims description 3
- 230000002708 enhancing effect Effects 0.000 claims 1
- 238000002474 experimental method Methods 0.000 abstract description 9
- 235000013305 food Nutrition 0.000 abstract description 9
- 230000036541 health Effects 0.000 abstract description 7
- 235000013361 beverage Nutrition 0.000 abstract description 4
- 238000013329 compounding Methods 0.000 abstract description 4
- 239000003814 drug Substances 0.000 abstract description 3
- 238000011156 evaluation Methods 0.000 abstract description 3
- 230000003750 conditioning effect Effects 0.000 abstract description 2
- 230000035622 drinking Effects 0.000 abstract description 2
- 229940079593 drug Drugs 0.000 abstract description 2
- 238000005516 engineering process Methods 0.000 abstract description 2
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- 238000012545 processing Methods 0.000 abstract description 2
- 230000001953 sensory effect Effects 0.000 abstract description 2
- 241001122767 Theaceae Species 0.000 abstract 1
- 210000000952 spleen Anatomy 0.000 description 30
- 206010062016 Immunosuppression Diseases 0.000 description 23
- 230000001506 immunosuppresive effect Effects 0.000 description 23
- 241000699666 Mus <mouse, genus> Species 0.000 description 15
- 210000002966 serum Anatomy 0.000 description 14
- 241000700159 Rattus Species 0.000 description 10
- 241001465754 Metazoa Species 0.000 description 9
- 241000699670 Mus sp. Species 0.000 description 8
- 108010026552 Proteome Proteins 0.000 description 8
- 210000000265 leukocyte Anatomy 0.000 description 8
- 210000004698 lymphocyte Anatomy 0.000 description 8
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 210000003743 erythrocyte Anatomy 0.000 description 6
- 229960005309 estradiol Drugs 0.000 description 6
- 229930182833 estradiol Natural products 0.000 description 6
- 238000003304 gavage Methods 0.000 description 6
- 239000013641 positive control Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 210000001541 thymus gland Anatomy 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 229940011871 estrogen Drugs 0.000 description 5
- 239000000262 estrogen Substances 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 210000005252 bulbus oculi Anatomy 0.000 description 3
- 239000006285 cell suspension Substances 0.000 description 3
- 230000007969 cellular immunity Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 230000004727 humoral immunity Effects 0.000 description 3
- 239000007928 intraperitoneal injection Substances 0.000 description 3
- 210000005259 peripheral blood Anatomy 0.000 description 3
- 239000011886 peripheral blood Substances 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- LOTKRQAVGJMPNV-UHFFFAOYSA-N 1-fluoro-2,4-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C([N+]([O-])=O)=C1 LOTKRQAVGJMPNV-UHFFFAOYSA-N 0.000 description 2
- 241000255783 Bombycidae Species 0.000 description 2
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 230000003044 adaptive effect Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 229960004397 cyclophosphamide Drugs 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 230000035931 haemagglutination Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 230000001678 irradiating effect Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 238000005096 rolling process Methods 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 230000014616 translation Effects 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 206010014025 Ear swelling Diseases 0.000 description 1
- 208000004262 Food Hypersensitivity Diseases 0.000 description 1
- 206010016946 Food allergy Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000012981 Hank's balanced salt solution Substances 0.000 description 1
- 108010006464 Hemolysin Proteins Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 210000000702 aorta abdominal Anatomy 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- CJDPJFRMHVXWPT-UHFFFAOYSA-N barium sulfide Chemical compound [S-2].[Ba+2] CJDPJFRMHVXWPT-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 239000000701 coagulant Substances 0.000 description 1
- 239000003026 cod liver oil Substances 0.000 description 1
- 235000012716 cod liver oil Nutrition 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- RGLYKWWBQGJZGM-ISLYRVAYSA-N diethylstilbestrol Chemical compound C=1C=C(O)C=CC=1C(/CC)=C(\CC)C1=CC=C(O)C=C1 RGLYKWWBQGJZGM-ISLYRVAYSA-N 0.000 description 1
- 229960000452 diethylstilbestrol Drugs 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 235000021186 dishes Nutrition 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000020932 food allergy Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000005337 ground glass Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 239000003228 hemolysin Substances 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000009806 oophorectomy Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 230000003393 splenic effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L21/00—Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
- A23L21/20—Products from apiculture, e.g. royal jelly or pollen; Substitutes therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/014—Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Insects & Arthropods (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Anesthesiology (AREA)
- Biochemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Microbiology (AREA)
- Animal Husbandry (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
组别 | 胸腺指数 | 脾脏指数 |
正常对照组 | 0.229±0.325 | 0.289±0.542 |
模型对照组 | 0.102±0.211<sup>▲▲</sup> | 0.192±0.351<sup>▲▲</sup> |
脾氨肽组 | 0.262±0.524** | 0.331±0.215** |
实施例1蛋白组 | 0.524±0.231**<sup>▲▲△△</sup> | 0.492±0.314**<sup>▲▲△</sup> |
组别 | 白细胞总数10<sup>9</sup>/L | 淋巴细胞数10<sup>9</sup>/L |
正常对照组 | 7.69±1.25 | 4.57±0.641 |
模型对照组 | 4.03±2.42<sup>▲▲</sup> | 2.61±0.532<sup>▲▲</sup> |
脾氨肽组 | 8.26±2.43** | 5.37±1.246** |
实施例1蛋白组 | 13.56±4.51**<sup>▲▲△△</sup> | 9.56±2.413**<sup>▲▲△△</sup> |
组别 | OD值 |
正常对照组 | 0.068±0.15 |
模型对照组 | 0.043±0.24<sup>▲</sup> |
脾氨肽组 | 0.068±0.13*<sup>▲</sup> |
实施例1蛋白组 | 0.164±0.02**<sup>▲▲△△</sup> |
组别 | 耳肿胀度mg |
正常对照组 | 4.52±0.523 |
模型对照组 | 3.18±1.241<sup>▲</sup> |
脾氨肽组 | 6.23±1.324**<sup>▲▲</sup> |
实施例1蛋白组 | 6.92±1.267**<sup>▲▲</sup> |
组别 | 抗体指数 |
正常对照组 | 186.4±54.23 |
模型对照组 | 113.2±23.54<sup>▲</sup> |
脾氨肽组 | 208.6±54.21** |
实施例1蛋白组 | 231.8±35.16**<sup>▲</sup> |
组别 | 动物数(只) | 血清雌二醇(pg/ml) |
正常对照组 | 10 | 66.15±12.51 |
模型对照组 | 10 | 47.91±11.24 |
阳性对照组 | 10 | 105.32±15.32*** |
实施例1蛋白组 | 10 | 116.29±23.52*** |
组别 | 动物数(只) | 血清雌二醇(pg/ml) |
正常对照组 | 10 | 68.42±11.32 |
模型对照组 | 10 | 49.23±13.21 |
阳性对照组 | 10 | 108.12±16.12*** |
第1组 | 10 | 102.15±26.24*** |
第2组 | 10 | 105.04±33.45*** |
第3组 | 10 | 119.54±12.31*** |
第4组 | 10 | 124.35±32.42*** |
第5组 | 10 | 108.34±27.23*** |
第6组 | 10 | 106.25±22.13*** |
组别 | 配方(质量比) |
组1 | 雌蚕蛹蛋白:雌蚕蛾粉:胶原蛋白肽:蜂王浆冻干粉:无水葡萄糖=75:10:5:5:5 |
组2 | 雌蚕蛹蛋白:雌蚕蛾粉:胶原蛋白肽:蜂王浆冻干粉=75:10:5:5 |
组3 | 雌蚕蛹蛋白:雌蚕蛾粉:胶原蛋白肽:无水葡萄糖=75:10:5:5 |
组4 | 雌蚕蛹蛋白:雌蚕蛾粉:蜂王浆冻干粉:无水葡萄糖=75:10:5:5 |
组5 | 雌蚕蛹蛋白:胶原蛋白肽:蜂王浆冻干粉:无水葡萄糖=75:5:5:5 |
组别 | 动物数(只) | 血清雌二醇(pg/ml) |
正常对照组 | 10 | 67.45±13.24 |
模型对照组 | 10 | 48.34±14.35 |
阳性对照组 | 10 | 107.22±16.54*** |
第1组 | 10 | 126.47±56.13*** |
第2组 | 10 | 118.12±22.42*** |
第3组 | 10 | 98.25±35.14<sup>▲</sup> |
第4组 | 10 | 87.14±51.62<sup>▲▲</sup> |
第5组 | 10 | 75.64±26.36<sup>▲▲</sup> |
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810495583.8A CN108402472B (zh) | 2018-05-22 | 2018-05-22 | 一种女用蚕蛹提取生物蛋白 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810495583.8A CN108402472B (zh) | 2018-05-22 | 2018-05-22 | 一种女用蚕蛹提取生物蛋白 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108402472A CN108402472A (zh) | 2018-08-17 |
CN108402472B true CN108402472B (zh) | 2021-08-24 |
Family
ID=63140210
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810495583.8A Active CN108402472B (zh) | 2018-05-22 | 2018-05-22 | 一种女用蚕蛹提取生物蛋白 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108402472B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109481670B (zh) * | 2018-12-13 | 2021-08-10 | 北京康比特体育科技股份有限公司 | 一种可缓解失眠和改善睡眠质量的组合物 |
CN111733201A (zh) * | 2019-03-25 | 2020-10-02 | 罗士柱 | 一种单性蚕蛹肽粉的制作方法 |
CN110616247A (zh) * | 2019-08-16 | 2019-12-27 | 大连百利天华制药有限公司 | 脾氨肽口服冻干粉活力快速测定方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1076616A (zh) * | 1993-05-24 | 1993-09-29 | 魏鹏飞 | 精制雄蚕蛾粉及其制法 |
CN101692903A (zh) * | 2009-10-14 | 2010-04-14 | 江苏老蚕坊蚕桑生物科技开发有限公司 | 蚕蛹蛾抗氧化抗衰老片食品及其生产工艺 |
CN102391935A (zh) * | 2011-11-21 | 2012-03-28 | 池宇 | 一种女士用保健酒 |
CN105039483A (zh) * | 2015-09-21 | 2015-11-11 | 广东海洋大学 | 一种鱼皮鱼鳞胶原蛋白肽的制备方法 |
CN105747207A (zh) * | 2016-03-15 | 2016-07-13 | 杨建玉 | 一种提高免疫力的保健品 |
CN107912760A (zh) * | 2017-11-17 | 2018-04-17 | 黑龙江康普生物科技有限公司 | 一种复合功能性雄蚕蛾粉及其应用 |
-
2018
- 2018-05-22 CN CN201810495583.8A patent/CN108402472B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1076616A (zh) * | 1993-05-24 | 1993-09-29 | 魏鹏飞 | 精制雄蚕蛾粉及其制法 |
CN101692903A (zh) * | 2009-10-14 | 2010-04-14 | 江苏老蚕坊蚕桑生物科技开发有限公司 | 蚕蛹蛾抗氧化抗衰老片食品及其生产工艺 |
CN102391935A (zh) * | 2011-11-21 | 2012-03-28 | 池宇 | 一种女士用保健酒 |
CN105039483A (zh) * | 2015-09-21 | 2015-11-11 | 广东海洋大学 | 一种鱼皮鱼鳞胶原蛋白肽的制备方法 |
CN105747207A (zh) * | 2016-03-15 | 2016-07-13 | 杨建玉 | 一种提高免疫力的保健品 |
CN107912760A (zh) * | 2017-11-17 | 2018-04-17 | 黑龙江康普生物科技有限公司 | 一种复合功能性雄蚕蛾粉及其应用 |
Non-Patent Citations (1)
Title |
---|
蚕蛹蛋白综合利用研究进展;穆利霞等;《广东农业科学》;20111210(第23期);第108页左栏第3段、右栏倒数第1段,第106页右栏第2段,第107页右栏第3段 * |
Also Published As
Publication number | Publication date |
---|---|
CN108402472A (zh) | 2018-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101606706B (zh) | 一种复合蜂产品原料的保健食品 | |
JP5667358B2 (ja) | 柑橘類果皮の麹菌発酵組成物 | |
JP2019506451A (ja) | ウォールナットオリゴペプチド粉及びその調製方法と使用 | |
CN108402472B (zh) | 一种女用蚕蛹提取生物蛋白 | |
CN108339112A (zh) | 一种用于促进创伤愈合、褥疮修复、术后应激性溃疡愈合的营养组合物 | |
JP2008174539A (ja) | 紫色の馬鈴薯を使用した肥満患者用の健康機能食品 | |
CN109730309A (zh) | 健脑益智安神缓解压力益智仁复合多肽营养素及制备方法 | |
CN107779488A (zh) | 一种蛋白核小球藻活性肽、组合物及制备方法 | |
JP4132635B2 (ja) | 未失活酵素強化組成物 | |
CN102613453A (zh) | 一种用于糖尿病患者的海洋生物型肠内营养制剂及其制备方法和用途 | |
CN110403200A (zh) | 葛仙米组合物及其在缓解眼部疲劳、改善眼部黄斑病变中的应用 | |
EP0292601A1 (en) | Anti aids drug extracted from lentinus edodes | |
CN106722258A (zh) | 一种虾青素阿胶糕及其制备方法 | |
CN106377541A (zh) | 一种多糖组合物及其应用 | |
JP2012229164A (ja) | 抗アレルギー物質、抗アレルギー剤及び食品 | |
CN109198635A (zh) | 一种具有增强免疫力功能的保健食品及其制备方法 | |
CN113678972A (zh) | 一种增强免疫力的组合物及其制备方法 | |
CN103555527B (zh) | 蛇肽保健酒及其制备方法 | |
CN104939098B (zh) | 一种增强骨免疫力、补钙锁钙的保健食品及其制备方法 | |
JP4365012B2 (ja) | 糖尿病発症抑制用組成物の製造方法並びに組成物 | |
CN108619483B (zh) | 一种可平衡膳食营养的降糖膳食蚕蛹提取生物蛋白 | |
KR20220017595A (ko) | 땅콩새싹원액 또는 땅콩새싹음료 제조방법 및 그에 따른 음료 그리고 음료조성물 | |
KR20040092302A (ko) | 모자반 추출물을 포함하는 항암활성을 갖는 건강보조식품 | |
CN109010367A (zh) | 牛初乳粉及其制备方法、制剂和在制备治疗肿瘤药物中的应用 | |
KR101806476B1 (ko) | 갈색거저리 추출물을 함유하는 해마신경재생 촉진용 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: Room 946, self made, No. 333 Jiufo Construction Road, Guangzhou Zhongxin Guangzhou Knowledge City, Guangzhou, Guangdong Province, 510642 Patentee after: Renweifeng Smart Technology (Guangdong) Co.,Ltd. Country or region after: China Address before: 510642 room 3056-1, building 18, Taishan District, South China Agricultural University, No. 483, Wushan Road, Tianhe District, Guangzhou, Guangdong Patentee before: GUANGZHOU RENWEIFENG BIOLOGICAL TECHNOLOGY CO.,LTD. Country or region before: China |
|
CP03 | Change of name, title or address |